Newsroom category: Depo-Provera

Pfizer’s ‘Depo-Provera’ Increases Risk of Brain Tumours 3.5 Times Compared to Combined Birth Control Pill According to New Study as Litigation Overseen by Levin Papantonio Rises to Over 550 Lawsuits

July 28, 2025

A new study published on 29 June 2025 in international peer-reviewed medical journal Expert Opinion on Drug Safety by Frey et al. (the Frey study) has found that use of depot medroxyprogesterone acetate(DMPA), which is manufactured by Pfizer Inc. (NYSE:PFE) and sold under the brand name Depo-Provera among others, for over one year is associated […]

Read More

Levin Papantonio Attorney Chris Paulos Sounds Alarm on Depo-Provera at MTMP Spring 2025: “The Data Is Just Horrific.”

April 15, 2025

Contraceptive maker Upjohn allegedly withheld info on animal deaths from regulators and marketed the drug globally without controlled testing on humans. In a powerful presentation that opened the mass torts litigation track at this year’s Mass Torts Made Perfect (MTMP) Spring 2025 conference, Levin Papantonio attorney Chris Paulos delivered a searing exposé on the long and troubling history behind […]

Read More

Levin Papantonio Attorneys Appointed to Leadership Positions in Depo-Provera Multidistrict Litigation

March 18, 2025

Levin Papantonio (LP) announced that LP attorneys Virginia Buchanan and Chris Paulos have been appointed to key leadership positions in the Depo-Provera Liability Litigation (MDL No. 3140). Judge M. Casey Rodgers entered the order appointing leadership on March 16, 2025. Virginia Buchanan has been appointed Co-Chair of the Plaintiffs’ Executive Committee and a member of the Trial Subcommittee, while Chris Paulos has been named Plaintiffs’ […]

Read More